skip to primary navigationskip to content

Maximilian Stammnitz

Maximilian Stammnitz

PhD student


Max is working on Tasmanian Devil Transmissible Cancer genetics, covering mainly computational analyses of next-generation DNA and RNA sequencing. He is a Gates Cambridge scholar and has joined the Transmissible Cancer Group in 2015.


Key Publications

James, S., Jennings, G., Kwon, Y.M., Stammnitz, M.R., et al. (2019). Tracing the rise of malignant cell lines: Distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devils. Evolutionary Applications 00, 1-9. doi:10.1111/eva.12831

Kwon, Y.M., Stammnitz, M.R., Wang, J., Swift, K., et al. (2018). Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases. Royal Society Open Science 5:180870. doi:10.1098/rsos.180870

Caldwell, A., Coleby, R., Tovar, C., Stammnitz, M.R., et al. (2018). The newly-arisen Devil Facial Tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer. eLife 7:e35314. doi:10.7554/eLife.35314

Stammnitz, M.R., *Coorens, T.H.H., *Gori, K.C., Hayes, D., et al. (2018). The origins and vulnerabilities of two transmissible cancers in Tasmanian devils. Cancer Cell 33(4), 607-619. doi:10.1016/j.ccell.2018.03.013

Giordano, F., Stammnitz, M.R., Murchison, E.P., Ning, Z. (2018). scanPAV: a pipeline for extracting presence-absence variations in genome pairs. Bioinformatics 34(17), 3022–3024. doi:10.1093/bioinformatics/bty189

*Agne, M., *Blank, I., *Emhardt, A.J., *Gäbelein, C.G., ..., *Stammnitz, M.R., et al. (2014). Modularized CRISPR/dCas9 Effector Toolkit for Target-Specific Gene Regulation. ACS Synthetic Biology 3(12). doi:10.1021/sb500035y

Human anti-cancer drugs could help treat transmissible cancers in Tasmanian devils

« July 2019 »